The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Exponent Inc

Nasdaq: EXPO
Last

(U.S.) $54.88

Today's change-0.34 -0.62%
Updated June 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Exponent Inc

Nasdaq: EXPO
Last

(U.S.) $54.88

Today's change-0.34 -0.62%
Updated June 28 4:00 PM EDT. Delayed by at least 15 minutes.

Exponent Inc down (U.S.)$0.34

Exponent Inc closed lower Tuesday, dropping (U.S.)$0.34 or 0.62% to (U.S.)$54.88. Shares have lost 2.37% over the last five days, but sit 3.40% below their 52-week high. This security has outperformed the S&P 500 by 25.07% during the last year.

Key company metrics

  • Open(U.S.) $55.49
  • Previous close(U.S.) $55.22
  • High(U.S.) $56.08
  • Low(U.S.) $54.63
  • Bid / Ask-- / --
  • YTD % change+9.87%
  • Volume116,833
  • Average volume (10-day)99,562
  • Average volume (1-month)96,637
  • Average volume (3-month)96,337
  • 52-week range(U.S.) $40.58 to (U.S.) $56.81
  • Beta0.82
  • Trailing P/E30.72×
  • P/E 1 year forward29.83×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.72
  • Dividend yield1.31%
  • Trailing EPS(U.S.) $1.79
Updated June 28 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+15.40%

Based on its net profit margin of 15.40%, Exponent Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.12%Sector:IndustrialsIndustry:Commercial Services & Supplies

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 01, 201604/01/2016Jan 01, 201601/01/2016Oct 02, 201510/02/2015Jul 03, 201507/03/2015
Revenue83747980
Total other revenue--------
Total revenue83747980
Gross profit27253229
Total cost of revenue56494750
Total operating expense67595861
Selling / general / administrative4444
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total7777
Operating income16142119
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax18161919
Income after tax15101212
Income tax, total2678
Net income15101212
Total adjustments to net income--------
Net income before extra. items15101212
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items15101212
Inc. avail. to common incl. extra. items15101212
Diluted net income15101212
Dilution adjustment--0----
Diluted weighted average shares27272727
Diluted EPS excluding extraordinary itemsvalue per share0.560.370.430.43
Dividends per sharevalue per share0.180.150.150.15
Diluted normalized EPSvalue per share0.560.370.430.43